Form 4 for EXC Exelon
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-31 · accession 0001109357-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-01-02 | 2023-12-31 | EXC | Lillie Charisse R | Dir | A - Grant | $39.21 | +1,052 | 2,849 | +59% | +$41.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock- deferred stock units | 2023-12-31 | A | A | 1,052 | $39.21 | 2,849 | I By Exelon Corp. Directors Deferred Stock Unit Plan | — | — | (F1) Balance includes 16 additional shares acquired through automatic dividend reinvestment. |